Detalles de la búsqueda
1.
Modeling the potential impact of pre-exposure prophylaxis for HIV among men who have sex with men in Cameroon.
BMC Infect Dis
; 22(1): 751, 2022 Sep 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-36163000
2.
HIV-1 drug resistance testing is essential for heavily-treated patients switching from first- to second-line regimens in resource-limited settings: evidence from routine clinical practice in Cameroon.
BMC Infect Dis
; 19(1): 246, 2019 Mar 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30871487
3.
Viral suppression in adults, adolescents and children receiving antiretroviral therapy in Cameroon: adolescents at high risk of virological failure in the era of "test and treat".
AIDS Res Ther
; 16(1): 36, 2019 11 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-31744517
4.
Gender-based violence against female sex workers in Cameroon: prevalence and associations with sexual HIV risk and access to health services and justice.
Sex Transm Infect
; 92(8): 599-604, 2016 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-27280972
5.
Predictors of poor retention on antiretroviral therapy as a major HIV drug resistance early warning indicator in Cameroon: results from a nationwide systematic random sampling.
BMC Infect Dis
; 16(1): 678, 2016 Nov 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-27846809
6.
Correlates of prior HIV testing among men who have sex with men in Cameroon: a cross-sectional analysis.
BMC Public Health
; 14: 1220, 2014 Nov 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-25424530
7.
Human papillomavirus positivity and cervical lesions in relation to HIV infection: a comparative assessment in the Cameroonian female population.
J Public Health Afr
; 14(9): 2334, 2023 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37942060
8.
Viral suppression in the era of transition to dolutegravir-based therapy in Cameroon: Children at high risk of virological failure due to the lowly transition in pediatrics.
Medicine (Baltimore)
; 102(20): e33737, 2023 May 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-37335723
9.
Evaluation of Circulating and Archived HIV-1 Integrase Drug-Resistance Variants among Patients on Third-Line ART in Cameroon: Implications for Dolutegravir-Containing Regimens in Resource-Limited Settings.
Microbiol Spectr
; 10(6): e0342022, 2022 12 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-36259973
10.
Dolutegravir-Based Regimen Ensures High Virological Success despite Prior Exposure to Efavirenz-Based First-LINE ART in Cameroon: An Evidence of a Successful Transition Model.
Viruses
; 15(1)2022 12 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-36680058
11.
Evidence for an enhanced HIV/AIDS policy and care in Cameroon: proceedings of the second Cameroon HIV Research Forum (CAM-HERO) 2021.
Pan Afr Med J
; 43: 92, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36699972
12.
Research priorities for accelerating the achievement of three 95 HIV goals in Cameroon: a consensus statement from the Cameroon HIV Research Forum (CAM-HERO).
Pan Afr Med J
; 40: 124, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34909092
13.
Outcomes of the first meeting of the CAMEROON HIV RESEARCH FORUM (CAM-HERO).
Pan Afr Med J
; 40: 166, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34970408
14.
Challenges and barriers to HIV service uptake and delivery along the HIV care cascade in Cameroon.
Pan Afr Med J
; 36: 37, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32774613
15.
The declining trend of HIV-Infection among pregnant women in Cameroon infers an epidemic decline in the general population.
Heliyon
; 6(6): e04118, 2020 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-32566779
16.
Highlighting a population-based re-emergence of Syphilis infection and assessing associated risk factors among pregnant women in Cameroon: Evidence from the 2009, 2012 and 2017 national sentinel surveillance surveys of HIV and syphilis.
PLoS One
; 15(11): e0241999, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33186360
17.
On estimating the number of people with known HIV positive status.
BMC Res Notes
; 13(1): 118, 2020 Feb 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-32106876
18.
[National profile of early warning indicators of HIV pharmaco-resistance in Cameroon]. / Profil national des indicateurs d'alerte précoce de la pharmaco-résistance du VIH au Cameroun.
Pan Afr Med J
; 37: 374, 2020.
Artículo
en Francés
| MEDLINE | ID: mdl-33796187
19.
First case of Dolutegravir and Darunavir/r multi drug-resistant HIV-1 in Cameroon following exposure to Raltegravir: lessons and implications in the era of transition to Dolutegravir-based regimens.
Antimicrob Resist Infect Control
; 9(1): 143, 2020 08 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-32843050
20.
Factors associated with risk of HIV-infection among pregnant women in Cameroon: Evidence from the 2016 national sentinel surveillance survey of HIV and syphilis.
PLoS One
; 14(4): e0208963, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30978189